These findings suggested that heterozygosity or homozygosity for the minor alleles of IFN-lambda3 SNPs may be clinically associated with increased tumor aerobic glycolysis, immunosuppression, tumor resistance to therapy, and poor survival of patients with RCC. The gene discussed is IFNL3; the disease is neoplasm.